Screening ICD-10-CM Alphabetical Index. The ICD-10-CM Alphabetical Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. There are 105 terms under the parent term 'Screening' in the ICD-10-CM Alphabetical Index. Screening. See Code: Z13.9.
Encounter for screening for cardiovascular disorders. Z13.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z13.6 became effective on October 1, 2018.
Elevated C-reactive protein (CRP) The 2019 edition of ICD-10-CM R79.82 became effective on October 1, 2018. This is the American ICD-10-CM version of R79.82 - other international versions of ICD-10 R79.82 may differ.
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous ICD-10 Diagnosis Codes For multi-target stool DNA (sDNA) test, use Z12.11 Encounter for screening for malignant neoplasm of colon and Z12.12 Encounter for screening for malignant neoplasm of rectum. See NCD 210.3 for a full list of applicable diagnosis codes.
Abnormal levels of other serum enzymes The 2022 edition of ICD-10-CM R74. 8 became effective on October 1, 2021. This is the American ICD-10-CM version of R74.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.
9.
8 Abnormal levels of other serum enzymes. Abnormal level of: acid phosphatase.
ICD-10 Code for Person consulting for explanation of examination or test findings- Z71. 2- Codify by AAPC.
Z00.00ICD-10 Code for Encounter for general adult medical examination without abnormal findings- Z00. 00- Codify by AAPC.
Code Z13. 89, encounter for screening for other disorder, is the ICD-10 code for depression screening.
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
89.
ICD-10-CM Code for Elevation of levels of liver transaminase levels R74. 01.
GGT is useful for diagnosis of liver disease or injury, exclusion of hepatobiliary involvement related to other diseases, and patient management during the resolution of existing disease or following injury.
Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
For multi-target stool DNA (sDNA) test, use Z12.11 Encounter for screening for malignant neoplasm of colon and Z12.12 Encounter for screening for malignant neoplasm of rectum.
For colorectal cancer screening using multitarget sDNA test, coverage applies to all Medicare patients who fall are:
For patients not meeting criteria for high risk, frequency limitations are: